Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6004-6024
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6004
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6004
Family | Subfamily | Alias | Site | Function in pancreatic cancer |
PRMTs | PRMT1 | HRMT1L2, HMT2, ANM1 | H4R3me2a | Increase the β-catenin protein level; Methylate Gli1 at R597[44,54] |
PRMT5 | HRMT1L5, SKB1, HSL7 | H3R2me2s | Silence the expression of the tumor suppressor FBW7; Promote EMT via activating EGFR/ AKT/β-catenin signaling[45,56,188,189] | |
KMTs | SMYD3 | ZNFN3A1, ZMYND1 | H4K5me3 | Affect the PC progression by regulating MMP-2; Potentiate Ras signaling through methylation of MAP3K2[62,64] |
EZH2 | KMT6, WVS, ENX-1 | H3K27me3 | Suppress miR-139-5p expression by upregulating H3K27me3; Repress the E-cadherin by tri-methylation of H3K27[78,190] |
- Citation: Liu XY, Guo CH, Xi ZY, Xu XQ, Zhao QY, Li LS, Wang Y. Histone methylation in pancreatic cancer and its clinical implications. World J Gastroenterol 2021; 27(36): 6004-6024
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6004.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6004